Best Lung Transplant Hospital in India | Cost of Lung Transplant in India | Fortis Healthcare A lung transplant is a surgical procedure wherein one or both afflicted lungs are substituted with viable lung(s) procured from a donor, aimed at restoring pulmonary function and improving overall health...
Reddy has released its generic version of Erlotinib for non-small cell lung cancer. At the same time, Cipla has widened its scope with the introduction of Nivolumab, which is also an immunotherapy drug. These players are capitalizing on cheap manufacturing costs in India to meet the treatment ...
Among all types of cancer present, this one is said to be responsible for maximum number of deaths all over the world. Fortunately, there is present treatment to cure this ailment. But this needs to be done by the best cancer specialist in India and during the earlier stages. Availing ...
Even though, new drugs have invigorated the global lung cancer therapeutics market, the expiry of patents on the current drugs may also negatively impact the market. As the cost of developing the drugs is increasing, it has forced the drug manufacturers to reduce their investments in research &...
Pathy S, Roy S, Malik PS et al. Treatment compliance and outcome in geriatric patients with locally advanced non-small cell lung cancer: experience from India. Ira- nian Journal of Cancer Prevention 2016; 9(6): e5481. doi: 10.17795/ ijcp-5481....
As lung cancer is a disease that may be asymptomatic in early stages, patients often present with advanced disease, where conventional treatment alone may not result in effective eradication of the cancer. Fortunately, thanks to advances in lung cancer treatment over t...
Total cost of treatment = RM130,000 of personal savings. Comments I had my first lesson about lung cancer some 22 years ago. The second patient of CA Care is VJ. He had lung cancer and had one side of his lung removed and underwent treatments at the “cancer hospital.” I was at ...
There remains a need for a widely available, non-toxic, cost-effective treatment approach for patients with moderate to severe COVID-19. Low dose radiotherapy (LDRT) is being evaluated across many institutions around the world as an anti-inflammatory/immunomodulatory approach against moderate to ...
The rising numerous obstacles is likely to limit market growth. What is China's Expected Share in 2023? China is likely to secure a significant CAGR of 9.2% in 2023. Recommendations Healthcare Lung Cancer Therapeutics Market November 2024 ...
UtilizingTP53hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer Yen-Han Tseng Trieu Thi My Tran Chi-Ying F. Huang ResearchOpen Access27 Jan 2025Cell Death Discovery Volume: 11, P: 26